Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Covington
AstraZeneca
Medtronic
Healthtrust
McKesson
Dow
Accenture
Moodys
QuintilesIMS

Generated: October 21, 2017

DrugPatentWatch Database Preview

SUFENTANIL CITRATE Drug Profile

« Back to Dashboard

What is the patent landscape for Sufentanil Citrate, and when can generic versions of Sufentanil Citrate launch?

Sufentanil Citrate is a drug marketed by Watson Labs, West-ward Pharms Int, and Hospira. and is included in three NDAs.

The generic ingredient in SUFENTANIL CITRATE is sufentanil citrate. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.

Summary for Tradename: SUFENTANIL CITRATE

US Patents:0
Applicants:3
NDAs:3
Suppliers / Packagers: see list2
Bulk Api Vendors: see list13
Clinical Trials: see list658
Patent Applications: see list385
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SUFENTANIL CITRATE at DailyMed

Pharmacology for Tradename: SUFENTANIL CITRATE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
SUFENTANIL CITRATE
sufentanil citrate
INJECTABLE;INJECTION074406-001Dec 15, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
SUFENTANIL CITRATE
sufentanil citrate
INJECTABLE;INJECTION074413-001Dec 15, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
SUFENTANIL CITRATE
sufentanil citrate
INJECTABLE;INJECTION074534-001Dec 11, 1996APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Harvard Business School
Johnson and Johnson
Citi
Fish and Richardson
Daiichi Sankyo
Chubb
US Army
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot